Clinical Trial Update: CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov entry describes a calcineurin inhibitor-free, bottom-up immunosuppression strategy for liver transplant recipients, currently conducted in Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Liver Disease

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of Regensburg | Conditions: Renal Impairment, Liver Transplantation | Phase 2, Phase 3 | Status: UNKNOWN